These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6303339

  • 1. Anti-mutagenic chalcones: antagonizing the mutagenicity of benzo(a)pyrene on Salmonella typhimurium.
    Torigoe T, Arisawa M, Itoh S, Fujiu M, Maruyama HB.
    Biochem Biophys Res Commun; 1983 May 16; 112(3):833-42. PubMed ID: 6303339
    [Abstract] [Full Text] [Related]

  • 2. Structure-mutagenicity relationships of chalcones and their oxides in the Salmonella assay.
    Rashid KA, Mullin CA, Mumma RO.
    Mutat Res; 1986 Mar 16; 169(3):71-9. PubMed ID: 3512996
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic, additive, and antagonistic mutagenic responses to binary mixtures of benzo(a)pyrene and benzo(e)pyrene as detected by strains TA98 and TA100 in the Salmonella/microsome assay.
    Hass BS, Brooks EE, Schumann KE, Dornfeld SS.
    Environ Mutagen; 1981 Mar 16; 3(2):159-66. PubMed ID: 6263605
    [Abstract] [Full Text] [Related]

  • 5. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
    Jongeneelen FJ, Leijdekkers CM, Bos RP, Theuws JL, Henderson PT.
    J Appl Toxicol; 1985 Oct 16; 5(5):277-82. PubMed ID: 3902943
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT, Wood AW, Chang RL, Yagi H, Sayer JM, Jerina DM, Conney AH.
    Cancer Res; 1986 Feb 16; 46(2):558-66. PubMed ID: 3079665
    [Abstract] [Full Text] [Related]

  • 7. Mutagenicity and co-mutagenicity of catechol on Salmonella.
    Yoshida D, Fukuhara Y.
    Mutat Res; 1983 Apr 16; 120(1):7-11. PubMed ID: 6339915
    [Abstract] [Full Text] [Related]

  • 8. Screening of antioxidants and other compounds for antimutagenic properties towards benzo[a]pyrene-induced mutagenicity in strain TA98 of Salmonella typhimurium.
    Calle LM, Sullivan PD.
    Mutat Res; 1982 Apr 16; 101(2):99-114. PubMed ID: 7048082
    [Abstract] [Full Text] [Related]

  • 9. The effect of substituted phenothiazines on the mutagenicity of benzo[a]pyrene.
    Kittle JD, Calle LM, Sullivan PD.
    Mutat Res; 1981 Feb 16; 80(2):259-64. PubMed ID: 7010139
    [Abstract] [Full Text] [Related]

  • 10. Bacterial mutagenicity of two cyclopentafused isomers of benzpyrene.
    Ball LM, Warren SH, Sangaiah R, Gold A.
    Mutat Res; 1991 Jul 16; 260(3):271-9. PubMed ID: 1870616
    [Abstract] [Full Text] [Related]

  • 11. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on mutagenesis by benzo[a]pyrene and aflatoxin B1 in the Salmonella/microsome assay.
    Malaveille C, Brun G, Hautefeuille A, Bartsch H.
    Mutat Res; 1981 Aug 16; 83(1):15-24. PubMed ID: 6268971
    [Abstract] [Full Text] [Related]

  • 12. Mutagenic effects of benzo[a]pyrene after metabolic activation by hepatic 9000 g supernatants or intact hepatocytes.
    Brouns RE, Bos RP, van Gemert PJ, Yih-van de Hurk EW, Henderson PT.
    Mutat Res; 1979 Aug 16; 62(1):19-26. PubMed ID: 386101
    [Abstract] [Full Text] [Related]

  • 13. Use of nitrous acid-dependent decrease in mutagenicity as an indication of the presence of mutagenic primary aromatic amines. Non-specific reactions with phenols and benzo[alpha]pyrene.
    Haugen DA, Peak MJ, Reilly CA.
    Mutat Res; 1981 Jun 16; 82(1):59-67. PubMed ID: 6267458
    [Abstract] [Full Text] [Related]

  • 14. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D, Glatt H, Oesch F.
    Cancer Res; 1987 Mar 15; 47(6):1509-15. PubMed ID: 3545447
    [Abstract] [Full Text] [Related]

  • 15. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.
    Wislocki PG, Wood AW, Chang RL, Levin W, Yagi H, Hernandez O, Dansette PM, Herina DM, Conney AH.
    Cancer Res; 1976 Sep 15; 36(9 pt.1):3350-7. PubMed ID: 788898
    [Abstract] [Full Text] [Related]

  • 16. Presentation of benzo(a)pyrene to microsomal enzymes by asbestos fibers in the Salmonella/mammalian microsome mutagenicity test.
    Szyba K, Lange A.
    Environ Health Perspect; 1983 Sep 15; 51():337-41. PubMed ID: 6315376
    [Abstract] [Full Text] [Related]

  • 17. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE, Scarpelli DG, Gill K.
    Cancer Res; 1981 Sep 15; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [Abstract] [Full Text] [Related]

  • 18. Nonmutagenicity of betel leaf and its antimutagenic action against environmental mutagens.
    Nagabhushan M, Amonkar AJ, D'Souza AV, Bhide SV.
    Neoplasma; 1987 Sep 15; 34(2):159-67. PubMed ID: 3110636
    [Abstract] [Full Text] [Related]

  • 19. The effect of solvents upon the yield of revertants in the Salmonella/activation mutagenicity assay.
    Anderson D, McGregor DB.
    Carcinogenesis; 1980 Apr 15; 1(4):363-6. PubMed ID: 6268317
    [Abstract] [Full Text] [Related]

  • 20. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H, Seidel A, Ribeiro O, Kirkby C, Hirom P, Oesch F.
    Carcinogenesis; 1987 Nov 15; 8(11):1621-7. PubMed ID: 3311446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.